VAXCYTE INC
PCVXNASDAQ🏆 #980 by market capEarnings Nov 2US Equity
$56.69▼ $1.54 (−2.71%)
🌙 After hours$57.51▲ 1.45%Regular close · extended-hours price shownTrack PCVX
Get earnings, price moves & breaking news on Telegram
24h▼ 2.7%
7d▼ 4.0%
14d▼ 4.2%
30d▼ 5.3%
ytd▲ 23.0%
1y▲ 63.5%
🏦Market Cap
$8.19B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
60
Fair
VAXCYTE INC
PCVXAnalyst Ratings
Price
$56.69
Total
11
Raised
0
Lowered
0
Avg PT
$105.57
H / L
$163 / $58
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
B of A Securities | Reiterated | Buy | 2026-09-28 | — | — |
Needham | Reiterated | Buy | 2026-09-25 | $58.00 | +2.30% |
BTIG | Reiterated | Buy | 2026-02-26 | $89.00 | +57.00% |
Guggenheim | Reiterated | Buy | 2026-02-02 | $66.00 | +16.40% |
Goldman Sachs | Reiterated | Buy | 2025-04-01 | — | — |
Mizuho | Reiterated | Outperform | 2024-09-10 | — | — |
Leerink Partners | Reiterated | Outperform | 2024-09-03 | $77.00 | +35.80% |
Jefferies | Reiterated | Buy | 2024-09-03 | $146.00 | +157.50% |
Cantor Fitzgerald | Reiterated | Overweight | 2023-08-22 | — | — |
TD Cowen | Reiterated | Outperform | 2023-04-18 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-12-16 | — | — |
Institution
B of A Securities
Reiterated · Buy · 2026-09-28
—
—
Needham
Reiterated · Buy · 2026-09-25
$58.00
+2.30%
BTIG
Reiterated · Buy · 2026-02-26
$89.00
+57.00%
Guggenheim
Reiterated · Buy · 2026-02-02
$66.00
+16.40%
Goldman Sachs
Reiterated · Buy · 2025-04-01
—
—
Mizuho
Reiterated · Outperform · 2024-09-10
—
—
Leerink Partners
Reiterated · Outperform · 2024-09-03
$77.00
+35.80%
Jefferies
Reiterated · Buy · 2024-09-03
$146.00
+157.50%
Cantor Fitzgerald
Reiterated · Overweight · 2023-08-22
—
—
TD Cowen
Reiterated · Outperform · 2023-04-18
—
—
SVB Leerink
Reiterated · Outperform · 2022-12-16
—
—
One row per institution · price target from the firm's latest published target